Loading clinical trials...
Loading clinical trials...
The study assess the pharmacodynamic effect and the tolerability of Grazax treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ALK-Abelló A/S
NCT07412990 · Grass Pollen Allergy
NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy
NCT05560698 · Grass Pollen Allergy, Rhinoconjunctivitis
NCT04435678 · Birch Pollen Allergy, Grass Pollen Allergy, and more
NCT01538979 · Grass Pollen Allergy
ALK-Abello A/S, Bøge alle 6-8
Hørsholm
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions